Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration

New data shows that human embryonic stem cells can be differentiated into liver progenitor cells and produce mature liver cells

2013-06-06

(Press-News.org) Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients with liver disease. Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional liver cells.

"The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy," said the study's senior author, Valerie Gouon-Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sinai. "Until now, liver transplantation has been the most successful treatment for people with liver failure, but we have a drastic shortage of organs. This discovery may help circumvent that problem."

In conjunction with the laboratory of Matthew J. Evans, PhD, from the Department of Microbiology at Icahn School of Medicine at Mount Sinai, investigators demonstrated the functionality of the liver cells generated from the progenitors, as the liver cells can be infected by the hepatitis C virus, a property restricted to liver cells exclusively.

A critical discovery in this research was finding that the novel progenitor has a receptor protein on its cell surface called KDR, or vascular endothelial growth factor receptor 2, which until now, was thought to be restricted to endothelial cells that form vessels, the progenitors for endothelial cells and the progenitors blood cells. The research team showed that activation of KDR on these novel liver progenitors differentiates them into mature liver cells. Additionally, work in a mouse model revealed similar cells, indicating that the progenitors are conserved from mouse to human, and therefore, they must be "important cells with promising potential for cell therapy in treating liver disease," explained Dr. Gouon-Evans.

Next, the research team will examine specifically whether these liver cells obtained from human embryonic stem cells in a dish help repair injured livers in preclinical animal models of liver disease.

### Funding for this study was provided by The Black Family Stem Cell Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Robin Chemers Neustein Postdoctoral Fellowship, the American Cancer Society, and Pew Charitable Funds.

About the Black Family Stem Cell Institute The Black Family Stem Cell Institute is Mount Sinai's foundation for both basic and disease-oriented research on embryonic and adult stem cells. The therapeutic use of stem cells is a promising area of medicine for the decades ahead and researchers are examining why stem cells function in certain types of niches, microenvironments, and pockets of activity. Investigators are working to break the code in stem cell communication by determining how stem cells signal one another and other cells. The new knowledge that will result from this research holds the promise of diagnostic and therapeutic breakthroughs.

Studies show that it is possible to reprogram adult skin cells into cells that are very similar to embryonic stem cells. Once stem cells can be grown and differentiated in a controlled way to replace degenerated cells and repair tissues, medical science may then be able to diagnose and cure many intractable diseases at their earliest stages, such as type 1 diabetes, Parkinson's disease, various cardiovascular diseases, liver disease, and cancer.

For more information, visit http://icahn.mssm.edu/research/institutes/black-family-stem-cell-institute/about-us

The Mount Sinai Medical Center The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2011, U.S. News & World Report ranked The Mount Sinai Hospital 16th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place. For more information http://www.mountsinai.org/. Find Mount Sinai on Facebook, Twitter and YouTube

ELSE PRESS RELEASES FROM THIS DATE:

Rewinding development: A step forward for stem cell research

2013-06-06

Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells. This significant discovery, published in the journal Cell Reports today, has the potential to shed new light on placenta related disorders that can lead to problematic pregnancies and miscarriages. Embryonic stem cells can make all kinds of adult cells in the human body such as muscle, blood or brain cells. However, these ...

Research reveals Europe winning war on undeclared work

2013-06-06

Research from the University of Sheffield has found that the wider range of policy approaches and measures which have been introduced in all EU Member States over the past five years have had a significant impact on preventing businesses and people from engaging in undeclared work. The research, led Professor Colin Williams from the University of Sheffield, found an incremental decline in the size of the undeclared economy from the equivalent of 22.3 percent of GDP in 2003 to 18.4 percent by 2012 - although with big differences between countries, revealing a clear north-south ...

Promising material for lithium-ion batteries

2013-06-06

This news release is available in German. Loading a lithium-ion battery produces lithium atoms that are taken up by the graphite layers of the negative electrode. However, the capacity of graphite is limited to one lithium atom per six carbon atoms. Silicon could take up to ten times more lithium. But unfortunately, it strongly expands during this process – which leads to unsolved problems in battery applications. Looking for an alternative to pure silicon, scientists at the Technische Universitaet Muenchen have now synthesized a novel framework structure consisting ...

2011 Draconid meteor shower deposited a ton of meteoritic material on Earth

2013-06-06

Every 6.6 years, the comet Giacobini-Zinner circulates through the inner solar system and passes through the perihelion, the closest point to the Sun of its orbit. Then, the comet sublimates the ices and ejects a large number of particles that are distributed in filaments. The oldest of these particles have formed a swarm that the Earth passes trough every year in early October. The result is a Draconid meteor shower –meteors from this comet come from the northern constellation Draco–, which hits the Earth's atmosphere at about 75,000 km/h, a relatively slow speed in comparison ...

MRI study: Breastfeeding boosts babies' brain growth

2013-06-06

PROVIDENCE, R.I. [Brown University] — A new study by researchers from Brown University finds more evidence that breastfeeding is good for babies' brains. The study made use of specialized, baby-friendly magnetic resonance imaging (MRI) to look at the brain growth in a sample of children under the age of 4. The research found that by age 2, babies who had been breastfed exclusively for at least three months had enhanced development in key parts of the brain compared to children who were fed formula exclusively or who were fed a combination of formula and breastmilk. The ...

Human Argonaute proteins: To slice or not to slice?

2013-06-06

Cold Spring Harbor, N.Y. – Human Argonautes (hAgo), are key proteins involved in a process known as RNA interference. RNAi, as it is often called, is a mechanism that cells use to regulate gene expression. Human Argonaute-2 (hAgo2) is known as "slicer" for its unique ability among the 4 human Argonaute proteins to directly cut messenger RNA -- which carries the information coded in genomic DNA to make a protein -- and thus disable "messages" generated from genes. The atomic resolution structure of hAgo2 solved previously, revealed the active site, a region of the enzyme ...

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added

2013-06-06

CHAPEL HILL, N.C. - While aspirin has been shown to be effective in preventing heart attacks in men, it also increases the risk of gastrointestinal bleeding and possibly stroke, even at low doses. As such, national guidelines suggest that aspirin be used for prevention only in men at higher risk for cardiovascular events, so that the benefits of aspirin are greater than its adverse effects. Recent data suggest that aspirin may also be effective for reducing cancer deaths. Would the possible combined health benefits of reducing heart attacks and cancer outweigh the risks ...

Unusual antibodies in cows suggest new ways to make therapies for people

2013-06-06

LA JOLLA, CA – June 6, 2013 – Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) focusing on an extraordinary family of cow antibodies points to new ways to make human medicines. "These antibodies' structure and their mechanism for creating diversity haven't been seen before in other animals' antibodies," said Vaughn V. Smider, assistant professor of cell and molecular biology at TSRI and principal investigator ...

Conservatives more likely than liberals to identify mixed-race individuals as Black, NYU study finds

2013-06-06

Conservatives are more likely than liberals to identify mixed-race individuals as Black, according to a series of new studies by researchers at New York University. Their findings, which appear in the Journal of Experimental Social Psychology, suggest that there is a link between political ideology and racial categorization. "A person's race is often thought to be clear-cut and fixed," explains Amy Krosch, a doctoral student in New York University's Department of Psychology and the lead author of the paper. "However, our research suggests that the perception of a person ...

Big multiple sclerosis breakthrough

2013-06-06

CHICAGO --- A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis (MS) patients showed the therapy was safe and dramatically reduced patients' immune systems' reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine research. In MS, the immune system attacks and destroys myelin, the insulating layer that forms around nerves in the spinal cord, brain and optic nerve. When the insulation is destroyed, electrical signals can't be effectively conducted, resulting in symptoms that range from mild limb numbness ...

Mount Sinai discovers new liver cell for cellular therapy to aid in liver regeneration

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: